Telocinobufagin is primarily studied for its potential in cancer research due to its ability to inhibit cancer cell growth and induce apoptosis. It has shown promise in targeting specific pathways involved in tumor progression, making it a candidate for developing anticancer therapies. Additionally, it is being explored for its cardiotonic properties, as it may enhance heart muscle contraction, which could be beneficial in treating certain cardiovascular conditions. Research is ongoing to fully understand its mechanisms and therapeutic applications.